Genewity B.V.
Rob Posthumus is currently serving as the Chief Legal Officer at Genewity B.V. and as the General Counsel at Triall. With a background in Dutch law, private law, and business law from Erasmus University Rotterdam, Rob has held various senior legal and executive roles in companies such as ViroNovative BV, Sovalacc BV, and Erasmus Centre for Entrepreneurship. Rob's experience also includes coordinating regional networks for Health and Life Sciences at Kennisalliantie Zuid-Holland and serving as the Statutory Director at Erasmus MC DiabetesStation B.V. Rob's expertise lies in building consortia, overseeing clinical trials, providing legal counsel, and driving business development in the healthcare and life sciences industries.
This person is not in any teams
This person is not in any offices
Genewity B.V.
Genewity B.V. is a recently founded biotech company based in Leiden, the Netherlands. Closely collaborating with the LUmc, we build on successes of our scientific and business teams in cell and gene therapies, including the first multi-centric clinical trial for gene therapy in the EU (the RAG1 SCID trial). Genewity has been founded to commercialize another potentially groundbreaking therapy for developing autologous thymus tissue de novo. Genewity is currently in a preclinical development stage and is engaged in raising a Series A to push the technology to the clinic.